CHRO

Channel Therapeutics Corporation

Exchange: nyse

Multiples
  • P/E: -1.46
  • P/BV: -1.48
  • P/TBV: -2.28

Description:

none

Data:

Market Cap

14708345.00

EBITDA

Net Income
Yields:

Earnings Yield

Return on Capital

CAGR (net income)

0%

CAGR Length

0

Dividend Rate
LTR RTL